
|


Medical Device and Diagnostics Public RelationsBioness, Inc. More than 200,000 people in the U.S. suffer a stroke each year, and millions more suffer from multiple sclerosis (MS), traumatic brain injury (TBI) and other conditions affecting the nervous system. The effects of these conditions on the nervous system are profound, and often leave individuals struggling with physical disability and deficits of the hand, arm and/or leg. These limitations are particularly frustrating because they take away a person’s independence. Not only are patients unable to do the things they love—such as sports and travel—but in some cases they are unable to simply complete the daily tasks of life, such as getting dressed in the morning, brushing their teeth, and cooking for themselves.
Enter Bioness, Inc., a company that has developed an advance in the field of neurostimulation that offers hope for those suffering from mobility issues following a neurological condition or event. Bioness’ devices are externally-worn neurostimulation systems designed to restore function and provide recovery to individuals who suffer from neurological conditions and disorders. The Foot Drop System L300™ is designed to target the roughly 2.5 million individuals in the U.S. who suffer from foot drop. The H200® Hand Rehab System is designed for the roughly 1.5 million individuals in the U.S. who suffer from upper extremity hemiparalysis often caused by stroke, TBI and SCI.
Bioness engaged Schwartz Communcations to promote its FES technologies at the community and trade level, and drive informed patient demand. While this campaign was successful, at the beginning of 2009 Bioness presented new business goals to Schwartz, focusing on the MS and stroke patient communities – Bioness’ two largest patient populations that had not been specifically targeted with the PR campaign. Bioness wanted to reach these large audiences through high profile national media, in addition to the grass roots local PR and trade exposure the company was receiving. EnteroMedics EnteroMedics, Inc. (St. Paul, Minn.) engaged Schwartz Communications to develop and implement a public relations campaign to help drive enrollment in the clinical trial of its VBLOC™ Therapy system for obesity. EnteroMedics developed an implantable, investigational device that could be a less-invasive alternative to surgery. VBLOC Therapy is intended to block signals carried on the vagus nerves between the brain and the digestive system that control sensations of hunger, satisfaction and fullness. Unlike bariatric surgeries, VBLOC Therapy does so without altering the anatomy.
When a clinical study has strict criteria for participation, a tight deadline and a tight budget, Schwartz has proven that PR can be a powerful and effective tool to recruit patients.
LifeCell
Retina Implant AG
SleepApneaInfo.com SleepApneaInfo.com is the world’s first educational web site devoted solely to obstructive sleep apnea (OSA) and serves as the educational landscape for an issue-awareness campaign, entitled, “Sleep Well, Be Healthy,” that was commissioned in May 2004. The non-branded awareness campaign is committed to educating the public about obstructive sleep apnea (OSA), its symptoms and effects, and helping to improve the lives of the 18 million Americans afflicted with the condition. By serving as an objective, comprehensive resource for OSA sufferers, their family and friends, SleepApneaInfo.com strives to raise awareness of the health risks of obstructive sleep apnea and make progress toward increasing diagnosis and treatment rates. For more information, visit www.SleepApneaInfo.com.
|


"I felt compelled to write you this morning because your firm has had one heck of an impact on my company and I thought you deserved to know. I'm not an easy client to please, nor an easy person to work with daily, so that alone should say something about how special your employees truly are. Thank you for giving JobKite a sense of pride we have been longing for."
Heather Galler, CEO, JobKite
|
|